Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betastatin: Propranolol, Carvedilol, and Rosuvastatin for Recurrent Variceal Hemorrhage
NCT03720067Phase 3Unknown
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in Portal Hypertension (PH), Variceal hemorrhage (VH), sponsored by Federal University of Rio de Janeiro. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
Portal Hypertension (PH)Variceal hemorrhage (VH)
Beyond the preview
Go deeper on NCT03720067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720067.